• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2500101 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products(3.3) Supplementary Application 2025-05-13 Yichang HEC Changjiang Pharmaceutical Co Ltd view
CYSB2500072 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2025-04-03 Gan & Lee Pharmaceuticals view
CXSL2400530 精蛋白人胰岛素混合注射液 (30R) human insulin;isophane protamine human insulin Injection Biological Products(3.3) New Drug Application 2024-08-10 Virtu Pharmako (Zhejiang) Co Ltd view
CYSB2400057 人胰岛素注射液 human insulin Injection Biological Products(3.3) Supplementary Application 2024-03-01 Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd view
CYSB2300234 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2023-12-21 Gan & Lee Pharmaceuticals view
CYSB2300203 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2023-11-03 Novo Nordisk (China) Pharmaceuticals Co Ltd view
CYSB2300105 精蛋白人胰岛素混合注射液(50R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2023-06-03 Novo Nordisk (China) Pharmaceuticals Co Ltd view
CXSS2300021 重组人胰岛素肠溶胶囊 Capsule Biological Products(2.1) New Drug Application 2023-04-25 Hefei Tianhui Incubator of Technologies Co Ltd view
CYSB2300060 人胰岛素注射液 human insulin Injection Biological Products(3.3) Supplementary Application 2023-03-11 Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd view
JYSZ2300008 人胰岛素注射液 human insulin Injection Biological Products License Renew 2023-02-14 Bioton SA;SciGen (Beijing) Biotechnology Co Ltd view
JYSZ2300006 人胰岛素注射液 human insulin Injection Biological Products License Renew 2023-02-14 Bioton SA;SciGen (Beijing) Biotechnology Co Ltd view
JYSZ2300007 人胰岛素注射液 human insulin Injection Biological Products License Renew 2023-02-14 Bioton SA;SciGen (Beijing) Biotechnology Co Ltd view
JYSZ2300009 人胰岛素注射液 human insulin Injection Biological Products License Renew 2023-02-14 Bioton SA;SciGen (Beijing) Biotechnology Co Ltd view
JYSZ2200062 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-11-08 Bioton SA;SciGen (Beijing) Biotechnology Co Ltd view
JYSZ2200061 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-11-08 Bioton SA;SciGen (Beijing) Biotechnology Co Ltd view
CYSB2200246 人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2022-10-12 Hefei Tianmai BIOTECHNOLOGY Development Co Ltd view
CYSB2200233 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2022-09-23 Gan & Lee Pharmaceuticals view
JYSZ2200026 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products License Renew 2022-06-24 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSZ2200022 精蛋白人胰岛素注射液 isophane protamine human insulin Injection Biological Products License Renew 2022-06-09 Novo Nordisk A/S view
JYSZ2200018 精蛋白人胰岛素注射液 isophane protamine human insulin Injection Biological Products License Renew 2022-04-25 Novo Nordisk A/S view